AwardTape · Defense awards · Medical · Health care services · W81XWH22D0016
W81XWH22D0016: $0 IDIQ contract to Creagen Inc
Creagen Inc holds an IDIQ contract from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $2.4M. Latest action Feb 11, 2026.
Small molecule synthesis idiq base award for usamriid
| PIID | W81XWH22D0016 |
|---|---|
| Type | IDIQ contract |
| Company | Creagen Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Health care services |
| PSC | Q301 REFERENCE LABORATORY TESTING |
| NAICS | 621511 MEDICAL LABORATORIES |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $2.4M |
| Base date | Sep 21, 2022 |
| Latest action | Feb 11, 2026 |
| End date | n/a |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial